Rosuvastatin 10 mg Tablet
Description
ROSUROOT-10
Rosuvastatin 10 mg Tablets
Division: DIABGLYM
Composition
Each film-coated tablet contains:
Rosuvastatin Calcium IP equivalent to Rosuvastatin — 10 mg
Excipients — q.s.
Colour: Approved colour used
Dosage form: Film-coated oral tablet
Product Description
ROSUROOT-10 contains Rosuvastatin 10 mg, a potent statin therapy formulated for the effective management of hypercholesterolemia, mixed dyslipidemia, diabetic dyslipidemia, and the prevention of atherosclerotic cardiovascular disease. Rosuvastatin is a highly effective HMG-CoA reductase inhibitor that significantly lowers LDL cholesterol, total cholesterol, non-HDL cholesterol, and triglycerides while improving HDL cholesterol levels.
Rosuvastatin 10 mg is widely prescribed for patients requiring effective lipid control and cardiovascular risk reduction. It helps reduce the progression of atherosclerosis, stabilize vulnerable plaques, improve endothelial function, and decrease the risk of major cardiovascular events such as myocardial infarction and ischemic stroke.
ROSUROOT-10 is particularly beneficial for patients with diabetes mellitus, hypertension, metabolic syndrome, obesity, chronic kidney disease, or a family history of cardiovascular disease. Long-term therapy contributes to improved lipid control and sustained cardiovascular protection.
Technical Knowledge of Rosuvastatin
Rosuvastatin selectively inhibits HMG-CoA reductase, the rate-limiting enzyme responsible for cholesterol biosynthesis in the liver. This inhibition reduces hepatic cholesterol production and increases LDL receptor expression, resulting in enhanced clearance of circulating LDL cholesterol from the bloodstream.
Rosuvastatin also decreases hepatic VLDL synthesis, reduces triglyceride-rich lipoproteins, improves endothelial nitric oxide activity, reduces vascular inflammation, and stabilizes atherosclerotic plaques. Its favorable pharmacokinetic profile and strong LDL-lowering efficacy make it one of the most effective statins available for long-term cardiovascular prevention.
Mechanism of Action
Rosuvastatin inhibits HMG-CoA reductase, reduces hepatic cholesterol synthesis, increases LDL receptor activity, lowers LDL cholesterol and total cholesterol, reduces VLDL production, improves endothelial function, decreases vascular inflammation, and stabilizes atherosclerotic plaques.
Key Benefits
Effective LDL cholesterol reduction
Reduces total cholesterol and non-HDL cholesterol
Lowers triglyceride levels
Improves HDL cholesterol
Slows progression of atherosclerosis
Stabilizes atherosclerotic plaques
Reduces the risk of myocardial infarction and ischemic stroke
Provides long-term cardiovascular protection
Suitable for sustained lipid management under medical supervision
Clinical Applications
ROSUROOT-10 is commonly prescribed for primary hypercholesterolemia, mixed dyslipidemia, diabetic dyslipidemia, familial hypercholesterolemia, coronary artery disease prevention, cardiovascular risk reduction, ischemic stroke prevention, peripheral arterial disease, and long-term lipid management in high-risk patients.
Facts About Rosuvastatin
Rosuvastatin is one of the most potent and extensively studied statins for LDL cholesterol reduction and cardiovascular risk reduction. It has strong clinical evidence supporting the prevention of major cardiovascular events and is recommended in multiple international cardiology and diabetes guidelines for patients requiring effective lipid-lowering therapy.
Key Facts
Potent statin therapy
Rosuvastatin 10 mg for effective LDL reduction
Provides cardiovascular and cerebrovascular protection
Supports long-term lipid management
Evidence-based therapy for atherosclerotic cardiovascular disease
Quality-assured pharmaceutical formulation
PCD Pharma Franchise Opportunity
ROSUROOT-10 is an excellent product for PCD Pharma Franchise, Cardiology Franchise, and Cardio-Diabetic Franchise across India. The increasing prevalence of dyslipidemia, diabetes, hypertension, obesity, and cardiovascular disease creates strong prescription demand and long-term market potential for this formulation.
Why Choose ROSUROOT-10 for PCD Pharma Franchise?
High prescription potential
Strong physician and cardiologist acceptance
Attractive monopoly franchise opportunity
Competitive pricing
Promotional support available
Visual aids and marketing inputs
Consistent product quality
Excellent repeat business potential
Third Party Manufacturing
Chemsroot Pharmaceutical offers Third Party Manufacturing of Rosuvastatin 10 mg Tablets with complete manufacturing support for pharmaceutical companies, marketers, exporters, and franchise businesses.
Our Third Party Manufacturing Services Include
Private label manufacturing
Contract manufacturing
Custom brand manufacturing
Loan license manufacturing
DCGI-compliant production
GMP-certified manufacturing
Batch manufacturing documentation
Product registration support
Customized packaging and artwork
Monopoly franchise packaging
Bulk manufacturing capability
Manufacturing Features
Pharmaceutical-grade raw materials
IP/BP/USP quality standards
In-process quality control
Finished product testing
Stability-oriented formulation
Moisture-controlled tablet manufacturing
Blister and Alu-Alu packaging options
ROSUROOT-10 from DIABGLYM combines effective lipid lowering, comprehensive cardiovascular protection, evidence-based statin therapy, and high-quality pharmaceutical manufacturing, making it an ideal product for physicians, cardiologists, diabetologists, PCD Pharma Franchise partners, and Third Party Manufacturing clients seeking a reliable Rosuvastatin formulation.
